MindMaze Therapeutics Holding (CHIX:MMTXZ) Days Inventory: 8,173.14 (As of Dec. 2025) — Near Median


CHIX:MMTXZ MindMaze Therapeutics Holding SA CHIX:MMTXZ
15 GF Score
Price CHF0.21
! 2 Warning Signs
View Full Analysis

What is MindMaze Therapeutics Holding Days Inventory?

MindMaze Therapeutics Holding CHIX:MMTXZ +4.74% 15 Days Inventory is 8,173.14 as of Dec. 2025, which is at its 10-year median of 8,173.14. GuruFocus rates CHIX:MMTXZ with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 638 Biotechnology companies, MindMaze Therapeutics Holding ranks worse than 98.43% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). MindMaze Therapeutics Holding's Average Total Inventories for the six months ended in Dec. 2025 was CHF1.14 Mil. MindMaze Therapeutics Holding's Cost of Goods Sold for the six months ended in Dec. 2025 was CHF0.05 Mil. Hence, MindMaze Therapeutics Holding's Days Inventory for the six months ended in Dec. 2025 was 4,086.57.

The historical rank and industry rank for MindMaze Therapeutics Holding's Days Inventory or its related term are showing as below:

CHIX:MMTXz' s Days Inventory Range Over the Past 10 Years
Min: 8173.14   Med: 8173.14   Max: 8173.14
Current: 8173.14

During the past 2 years, MindMaze Therapeutics Holding's highest Days Inventory was 8173.14. The lowest was 8173.14. And the median was 8173.14.

CHIX:MMTXz's Days Inventory is ranked worse than
98.43% of 638 companies
in the Biotechnology industry
Industry Median: 183.875 vs CHIX:MMTXz: 8173.14

MindMaze Therapeutics Holding's Days Inventory increased from . 20 (0.00) to Dec. 2025 (8,173.14). It might indicate that MindMaze Therapeutics Holding's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. MindMaze Therapeutics Holding's Inventory Turnover for the six months ended in Dec. 2025 was 0.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. MindMaze Therapeutics Holding's Inventory-to-Revenue for the six months ended in Dec. 2025 was 1.78.


MindMaze Therapeutics Holding  (CHIX:MMTXz) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

MindMaze Therapeutics Holding's Inventory Turnover for the six months ended in Dec. 2025 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

MindMaze Therapeutics Holding's Inventory to Revenue for the six months ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


MindMaze Therapeutics Holding Days Inventory Related Terms


MindMaze Therapeutics Holding Days Inventory Historical Data

* Premium members only.

The historical data trend for MindMaze Therapeutics Holding's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindMaze Therapeutics Holding Days Inventory Chart

MindMaze Therapeutics Holding Annual Data
Trend Dec24 Dec25
Days Inventory
0.00 8,173.14

MindMaze Therapeutics Holding Semi-Annual Data
Dec24 Dec25
Days Inventory 0.00 8,173.14

CHIX:MMTXZ vs VRTX, REGN, ALNY: Days Inventory Comparison

For the Biotechnology subindustry, MindMaze Therapeutics Holding's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MindMaze Therapeutics Holding Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindMaze Therapeutics Holding's Days Inventory distribution charts can be found below:

* The bar in red indicates where MindMaze Therapeutics Holding's Days Inventory falls into.


CHIX:MMTXZ
15GF Score
MindMaze Therapeutics Holding SA CHIX:MMTXZ
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindMaze Therapeutics Holding Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

MindMaze Therapeutics Holding's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0 + 1.142) / 1 ) / 0.051*365
=1.142 / 0.051*365
=8,173.14

MindMaze Therapeutics Holding's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

Days Inventory (Q: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2024 ) + Total Inventories (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0 + 1.142) / 1 ) / 0.051*365 / 2
=1.142 / 0.051*365 / 2
=4,086.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 8,173.14 mean?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a Days Inventory of 8,173.14 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MindMaze Therapeutics Holding and its competitors. This is near median its historical median of 8,173.14. Over the past decade, MindMaze Therapeutics Holding's Days Inventory has ranged from 8,173.14 to 8,173.14. According to the industry distribution chart, MindMaze Therapeutics Holding ranks #628 out of 638 companies in the Biotechnology industry, placing it in the top 98.4%.
Is MindMaze Therapeutics Holding's Days Inventory too high?
MindMaze Therapeutics Holding's current Days Inventory of 8,173.14 is near median its 10-year median of 8,173.14. Over the past 10 years, this metric has ranged from a low of 8,173.14 to a high of 8,173.14. The Biotechnology industry median Days Inventory is 183.88. MindMaze Therapeutics Holding's value of 8,173.14 is 4344.9% above this industry median. Based on the distribution chart, MindMaze Therapeutics Holding ranks #628 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, MindMaze Therapeutics Holding has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does MindMaze Therapeutics Holding's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MindMaze Therapeutics Holding ranks #628 out of 638 companies for Days Inventory. This places MindMaze Therapeutics Holding in the lower half of its industry. The industry median Days Inventory is 183.88. MindMaze Therapeutics Holding's value of 8,173.14 is 4344.9% above this benchmark. Historically, MindMaze Therapeutics Holding's own Days Inventory has ranged from 8,173.14 to 8,173.14 over the past decade. While the company's 10-year median is 8,173.14 vs. the industry median of 183.88, MindMaze Therapeutics Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MindMaze Therapeutics Holding's current Days Inventory of 8,173.14 is 4344.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MindMaze Therapeutics Holding and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MindMaze Therapeutics Holding's current Days Inventory is 8,173.14, which is near median its own 10-year median of 8,173.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindMaze Therapeutics Holding stock overvalued right now?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a current Days Inventory of 8,173.14. The current Days Inventory is 8,173.14, which is near median its 10-year median of 8,173.14 and 4344.9% above the Biotechnology industry median of 183.88. MindMaze Therapeutics Holding's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For MindMaze Therapeutics Holding (CHIX:MMTXZ), the current Days Inventory is 8,173.14 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MindMaze Therapeutics Holding Business Description

Other Exchanges RLFTY:USAMMTX:Switzerland
Address Avenue de Secheron 15, Geneva, CHE, 1202
MindMaze Therapeutics Holding SA is a Swiss-based, commercial-stage biopharmaceutical and neurotechnology company. The company develops and commercializes digital treatments for neurological diseases and brain disorders. Its technology platform integrates software, sensors, and telehealth, and its solutions are used in clinical and home settings internationally. The company has developed evidence-based, next-generation neurotherapeutics that provide evidence-based motor and cognitive treatments to redefine clinical outcomes in patients with neurological disease and brain disorders. The company also manages Relief's existing portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.
15GF Score

Get the complete analysis for CHIX:MMTXZ

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF0.21
Price